SCORPIUS HOLDINGS INC (SCPX) Stock Price, Quote, News and Overview
NYSEARCA:SCPX - NYSE Arca - US42237K5083 - Common Stock - Currency: USD
SCPX Quote, Performance and Key Statistics
0.203
-0.02 (-10.96%)
The current stock price of SCPX is 0.203 USD. In the past month the price decreased by -26.45%.
SCPX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.85 | 354.98B | ||
| AMGN | AMGEN INC | 15.03 | 159.99B | ||
| GILD | GILEAD SCIENCES INC | 23.87 | 137.10B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1656.31 | 123.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.25 | 76.09B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.34B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.37B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.26B | ||
| ONC | BEIGENE LTD-ADR | N/A | 26.06B | ||
| NTRA | NATERA INC | N/A | 22.20B | ||
| BIIB | BIOGEN INC | 8.32 | 19.98B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.01B |
Related stock screener links
About SCPX
Company Profile
Scorpius Holdings Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Morrisville, North Carolina and currently employs 82 full-time employees. The company went IPO on 2013-07-24. Scorpius Holdings, Inc. is a contract development and manufacturing organization (CDMO) that provides process development and biomanufacturing services to support the biomanufacturing needs of third parties who use its biomanufacturing capacity as a fee-for-service model through its subsidiary, Scorpius Biomanufacturing, Inc. The firm couples Current Good Manufacturing Practices (CGMP) biomanufacturing and quality control knowledge with capabilities in immunoassays, molecular assays, and bioanalytical methods to support cell- and gene-based therapies as well as large molecule biologics using American-made equipment, reagents, and materials. The company offers an array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio, Texas. The firm's CDMO service offerings also include enhanced microbial and mammalian development and manufacturing services.
Company Info
SCORPIUS HOLDINGS INC
627 Davis Drive, Suite 300
Morrisville NORTH CAROLINA US
Employees: 83
Company Website: https://www.nighthawkbio.com/
Investor Relations: https://www.nighthawkbio.com/investors-news
Phone: 19192407133
SCORPIUS HOLDINGS INC / SCPX FAQ
What is the stock price of SCORPIUS HOLDINGS INC today?
The current stock price of SCPX is 0.203 USD. The price decreased by -10.96% in the last trading session.
What is the ticker symbol for SCORPIUS HOLDINGS INC stock?
The exchange symbol of SCORPIUS HOLDINGS INC is SCPX and it is listed on the NYSE Arca exchange.
On which exchange is SCPX stock listed?
SCPX stock is listed on the NYSE Arca exchange.
What is the price forecast or stock price prediction for SCORPIUS HOLDINGS INC stock?
7 analysts have analysed SCPX and the average price target is 5.1 USD. This implies a price increase of 2412.32% is expected in the next year compared to the current price of 0.203. Check the SCORPIUS HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is SCORPIUS HOLDINGS INC worth?
SCORPIUS HOLDINGS INC (SCPX) has a market capitalization of 988.61K USD. This makes SCPX a Nano Cap stock.
How many employees does SCORPIUS HOLDINGS INC have?
SCORPIUS HOLDINGS INC (SCPX) currently has 83 employees.
What are the support and resistance levels for SCORPIUS HOLDINGS INC (SCPX) stock?
SCORPIUS HOLDINGS INC (SCPX) has a resistance level at 0.3. Check the full technical report for a detailed analysis of SCPX support and resistance levels.
Is SCORPIUS HOLDINGS INC (SCPX) expected to grow?
The Revenue of SCORPIUS HOLDINGS INC (SCPX) is expected to grow by 63.27% in the next year. Check the estimates tab for more information on the SCPX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SCORPIUS HOLDINGS INC (SCPX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SCPX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SCPX, evaluating the profitability, health, valuation and growth aspects
- SCORPIUS HOLDINGS INC (SCPX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SCORPIUS HOLDINGS INC (SCPX) Sales and EPS estimates to see what analysts future expectations are.
- SCORPIUS HOLDINGS INC (SCPX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SCORPIUS HOLDINGS INC (SCPX) Insider and Institutional Ownership to learn about the owners and their transactions.
- SCORPIUS HOLDINGS INC (SCPX) Stock Chart to make your own analysis
- SCORPIUS HOLDINGS INC (SCPX) Latest news and press-releases to stay up to date.
Does SCORPIUS HOLDINGS INC (SCPX) stock pay dividends?
SCPX does not pay a dividend.
When does SCORPIUS HOLDINGS INC (SCPX) report earnings?
SCORPIUS HOLDINGS INC (SCPX) will report earnings on 2025-04-24, after the market close.
What is the Price/Earnings (PE) ratio of SCORPIUS HOLDINGS INC (SCPX)?
SCORPIUS HOLDINGS INC (SCPX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.38).
What is the Short Interest ratio of SCORPIUS HOLDINGS INC (SCPX) stock?
The outstanding short interest for SCORPIUS HOLDINGS INC (SCPX) is 197.02% of its float. Check the ownership tab for more information on the SCPX short interest.
SCPX Technical Analysis
SCPX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to SCPX. SCPX has a bad profitability rating. Also its financial health evaluation is rather negative.
SCPX Financial Highlights
Over the last trailing twelve months SCPX reported a non-GAAP Earnings per Share(EPS) of -1.38. The EPS increased by 20.42% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -72.96% | ||
| ROE | -128.83% | ||
| Debt/Equity | 0.31 |
SCPX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to SCPX. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 97.7% and a revenue growth 63.27% for SCPX